At the industry's top events, pharma professionals can dive into these issues and more through educational sessions, networking events and keynote presentations from industry leaders. Here's a look at ...
Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...
Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026" has been added to ResearchAndMarkets.com's offering. The Manufacturing and ...
September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.
While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...
(MENAFN- GlobeNewsWire - Nasdaq) Report Combines Comprehensive Deal Data, Financial Benchmarking and Access to Real SEC-Filed Contracts to Support Asset Acquisition Strategy for Business Development, ...
LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026" has been added to ...
Currently, SXTC is trading at $6.60, up 456.59%. VERAXA Biotech develops next-generation antibody-based cancer therapies, including BiTAC T cell engagers and bispecific antibody-drug conjugates.The ...
Hosted on MSN
Vertex Pharmaceuticals just hit an all-time high. Here's why the biotech stock could soar even more
Vertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area. The company is slowly developing and launching medicines in other markets. These 10 stocks could mint the next ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Fully revised and updated, the report analyzes asset purchase agreements announced since 2019, giving business development, licensing, and corporate strategy professionals a detailed view of how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results